These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6196112)

  • 1. Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology.
    Allen RM
    Clin Neuropharmacol; 1983; 6 Suppl 1():S64-73. PubMed ID: 6196112
    [No Abstract]   [Full Text] [Related]  

  • 2. Amantadine in the management of extrapyramidal side effects.
    Borison RL
    Clin Neuropharmacol; 1983; 6 Suppl 1():S57-63. PubMed ID: 6139167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amantadine in malignant neuroleptic syndrome].
    Rojtman M; Apter E; Lahav S; Tiano S
    Harefuah; 1981 Apr; 100(7):333. PubMed ID: 6115795
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
    DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
    Psychopharmacol Bull; 1977 Jul; 13(3):31-3. PubMed ID: 18755
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of amantadine on prolactin levels and galactorrhea on neuroleptic-treated patients.
    Siever LJ
    J Clin Psychopharmacol; 1981 Jan; 1(1):2-7. PubMed ID: 6117579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and clinical effects of amantadine in drug-induced extrapyramidal symptoms.
    Greenblatt DJ; DiMascio A; Harmatz JS; Bernardo DL; Marder JE
    J Clin Pharmacol; 1977; 17(11-12):704-8. PubMed ID: 336651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Casey DE
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321
    [No Abstract]   [Full Text] [Related]  

  • 9. Amantadine in extrapyramidal syndromes induced by neuroleptic drugs.
    Dencker SJ; Lindberg D; Malm U
    Nord Psykiatr Tidsskr; 1973; 27(1):31-4. PubMed ID: 4687749
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
    Stenson RL; Donion PT; Meyer JE
    Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P; Robotti E; Nardini M
    Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
    [No Abstract]   [Full Text] [Related]  

  • 12. The neuroleptic malignant syndrome. A priority system.
    Neppe VM
    S Afr Med J; 1984 Mar; 65(13):523-5. PubMed ID: 6143410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
    DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
    Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacologic treatment of neuroleptic-induced akathisia.
    Fleischhacker WW; Roth SD; Kane JM
    J Clin Psychopharmacol; 1990 Feb; 10(1):12-21. PubMed ID: 1968470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
    Wasik A
    Psychiatr Pol; 1973; 7(1):51-6. PubMed ID: 4715833
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
    Pöldinger W
    Int Pharmacopsychiatry; 1978; 13(4):230-3. PubMed ID: 32149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium therapy for neuroleptic-induced extrapyramidal symptoms.
    Fernando ML; Manchanda R
    Br J Psychiatry; 1988 May; 152():722-3. PubMed ID: 2901889
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correction of an extrapyramidal neuroleptic syndrome with tryptophan and the dynamics of its concentration in the blood of patients].
    Balakleevskiĭ AI; Mitiukova TA; Vazhenin MM; Gaĭduk FM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):95-7. PubMed ID: 6112836
    [No Abstract]   [Full Text] [Related]  

  • 19. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.